Skip to main content

What the FDA labels say about taking them together

Olanzapine and omeprazole

Olanzapine's FDA label of March 5, 2026 names omeprazole in its drug interactions section; the omeprazole labels PlainMeds reads (2) do not name olanzapine. The olanzapine label: “Inducers of CYP1A2 or Glucuronyl Transferase – Omeprazole and rifampin may cause an increase in olanzapine clearance.”

Check it at the source: the olanzapine FDA label on DailyMed (effective March 5, 2026, Macleods Pharmaceuticals Limited); the omeprazole FDA label on DailyMed (effective April 22, 2024, Apotex Corp).

What does the olanzapine label say about omeprazole?

Olanzapine label, drug interactions

Inducers of CYP1A2 or Glucuronyl Transferase – Omeprazole and rifampin may cause an increase in olanzapine clearance.

Source: FDA drug label (Zyprexa Relprevv, NDA022173), H2-Pharma LLC, effective May 19, 2026 (SPL set 11544cba-64a9-49cb-8d74-da228053b252), via openFDA

Source: FDA drug label (Olanzapine), Macleods Pharmaceuticals Limited, effective March 5, 2026 (SPL set 8e095987-bdea-42f2-9550-c7155cf07d30), via openFDA; the full label on DailyMed

What does the omeprazole label say about olanzapine?

Omeprazole's label (effective April 22, 2024) and its 1 other brand-application label do not name olanzapine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Omeprazole), Apotex Corp, effective April 22, 2024 (SPL set b83329ac-a65e-b3af-a3fb-c5a6c740e5e7), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

43Olanzapine generic labelers
118Omeprazole generic labelers
OlanzapineOmeprazole
Labeled forSchizophrenia, Bipolar disorder, DepressionAcid reflux and ulcers
Boxed warningYesNo
Pharmacy cost (NADAC)$0.147 per tablet 20 mg tablet$0.0295 per capsule 20 mg capsule
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?